Department of Neurosurgery, Oslo University Hospital, Postboks 4054, Nydalen, 0407, Oslo, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.
Acta Neurochir (Wien). 2018 Jun;160(6):1207-1214. doi: 10.1007/s00701-018-3550-8. Epub 2018 Apr 22.
The object of this study was to delineate long-term results of the surgical treatment of pediatric tumors classified as ganglioglioma or gangliocytoma.
A cohort of consecutive patients 19 years or younger who had undergone primary resection of CNS tumors during the years 1980-2016 at a single institution were reviewed in this retrospective study of surgical morbidity, mortality, and academic achievement and/or work participation. Gross motor function and activities of daily living were scored using the Barthel Index (BI).
Patient records for 32 consecutive children and adolescents who had undergone resection for a ganglioglioma were included in this study. Of the 32 patients, 13 were in the first decade at the first surgery, whereas 19 were in the second decade. The male/female ratio was 1.0 (16/16). No patient was lost to follow-up. The tumor was localized to the supratentorial compartment in 26 patients, to the posterior fossa in 5 patients, and to the spinal cord in 1 patient. Only two of the tumors were classified as anaplastic. Of the 30 low-grade tumors, 2 were classified as gangliocytomas, 6 were desmoplastic infantile gangliogliomas, and 22 were ordinary gangliogliomas. The aim of primary surgery was gross-total resection (GTR) and was achieved in 23 patients (71.9%). Altogether, 43 tumor resections were performed. Eight patients underwent a second resection from 1 to 10 years after primary surgery and three of these also had a third resection from 2 to 24 years after initial surgery. The reason for further resection was clinical (seizure control failure/recurrence of epilepsy or progressive neurological deficit) and/or residual tumor progression/recurrence. There was no operative mortality in this series and all 32 patients are alive with follow-up periods from 0.5 to 36 years (median 14 years). Observed 14-year survival is thus 100%. One out of two children with primary anaplastic tumor received local radiotherapy (proton) postoperatively. The other 31 patients did not have any kind of non-surgical adjuvant therapy. Twenty-one out of 26 children with supratentorial tumor had epilepsy as one of their presenting symptoms. Nineteen of these became seizure-free after initial surgery (18 of them after GTR), but 3 patients experienced recurrence of seizures within some years. Functional outcome in terms of ADL, schooling, and work participation was gratifying in most patients. Five patients have persistent hydrocephalus (HC), treated with ventriculoperitoneal (VP) shunts.
Low-grade gangliogliomas (GGs) can be surgically treated with good long-term results including seizure and tumor control as well as school and working participation.
本研究旨在描绘经手术治疗的儿科肿瘤(归类为神经节细胞瘤或神经节细胞胶质瘤)的长期结果。
本回顾性研究分析了在单家机构接受原发性中枢神经系统肿瘤切除术的连续患者队列的手术发病率、死亡率以及学业成绩和/或工作参与情况。采用巴氏量表(Barthel Index,BI)对总体运动功能和日常生活活动能力进行评分。
本研究纳入了 32 例连续接受神经节细胞瘤切除术的儿童和青少年患者的病历记录。在 32 例患者中,13 例在第一次手术时处于第一个十年,19 例处于第二个十年。男女比例为 1.0(16/16)。无患者失访。肿瘤位于幕上腔的有 26 例,位于后颅窝的有 5 例,位于脊髓的有 1 例。仅有 2 个肿瘤被归类为间变性。在 30 个低级别肿瘤中,2 个被归类为神经节细胞胶质瘤,6 个为促纤维增生性婴儿型神经节细胞瘤,22 个为普通神经节细胞瘤。初次手术的主要目标是大体全切除(gross-total resection,GTR),有 23 例(71.9%)实现了这一目标。总共进行了 43 次肿瘤切除术。8 例患者在初次手术后 1 至 10 年内进行了第二次切除,其中 3 例在初次手术后 2 至 24 年内进行了第三次切除。再次切除的原因是临床原因(癫痫控制失败/癫痫复发或进行性神经功能缺损)和/或残留肿瘤进展/复发。本系列手术无手术死亡,所有 32 例患者均存活,随访时间为 0.5 至 36 年(中位随访时间 14 年)。因此,观察到的 14 年生存率为 100%。两名原发性间变性肿瘤患儿中的 1 人在术后接受了局部质子放疗。其余 31 例患者未接受任何非手术辅助治疗。26 例幕上肿瘤患儿中有 21 例以癫痫为首发症状之一。这些患儿中,18 例在初次手术后(18 例在 GTR 后)癫痫得到控制,但 3 例患儿在几年内复发癫痫。在大多数患者中,日常生活活动、学业和工作参与方面的功能结果令人满意。5 例患者有持续性脑积水(hydrocephalus,HC),通过脑室-腹腔分流术(ventriculoperitoneal shunt,VP)进行治疗。
低级别神经节细胞瘤(ganglioglioma,GG)可通过手术治疗,获得良好的长期结果,包括癫痫和肿瘤控制以及学业和工作参与。